Clinical Trial

Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment

Name: Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment — clinical trial record (NCT07606625)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The purpose of this study is to examine the impact of nasal spray treatment on Meibomian gland function and ocular surface health in symptomatic dry eye patients with mild to moderate Meibomian gland dysfunction (MGD).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-05-19.

Trial Details

NCT Number	NCT07606625
Lead Sponsor	University of California, Berkeley Collaborators: Viatris Inc.
Conditions	Dry Eye, Meibomian Gland Dysfunction
Enrollment	65 participants
Start Date	2026-03-06
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-27